AT
Actinogen Medical Limited
ATGGF · OTC
$0.04 +0.00% (+$0.00)
1M -12.50%
Market Cap $180.2M
P/E Ratio -
Div. Yield -
ROE 85.31%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 8.44x
P/E N/A
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 16.77%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 58.92%
ROE 85.31%
ROA 52.03%
Debt
69 /100
Low Debt/Equity 0.22x
Current ratio 3.45x
Int. coverage -60.34x
Stability
56 /100
Moderate Beta 0.89x
Rev. volatility 105.05%
EPS volatility 11.80%
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o ATGGF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven G. Gourlay
Employees
6
Headquarters
Sydney
Nadchodzące wydarzenia
24 LUT
Earnings
Upcoming earnings report